[1]王磊,姚淮芳.复方三七护脉汤联合西医常规治疗心血瘀阻型冠心病稳定型心绞痛20例临床观察[J].甘肃中医药大学学报,2019,36(03):48-51.[doi:10.16841/j.issn1003-8450.2019.03.10]
 WANG Lei,YAO Huaifang.Clinical observation on 20 cases of stable angina pectoris of coronary heart disease with stagnation of the heart blood type treated by Fufang Sanqi Humai Tang(复方三七护脉汤) combined with routine Western medicine treatment[J].Journal of Gansu University of Chinese Medicine,2019,36(03):48-51.[doi:10.16841/j.issn1003-8450.2019.03.10]
点击复制

复方三七护脉汤联合西医常规治疗心血瘀阻型冠心病稳定型心绞痛20例临床观察()
分享到:

《甘肃中医药大学学报》[ISSN:1003-8450/CN:62-1062/R]

卷:
36卷
期数:
2019年03期
页码:
48-51
栏目:
临床研究与报道
出版日期:
2019-06-25

文章信息/Info

Title:
Clinical observation on 20 cases of stable angina pectoris of coronary heart disease with stagnation of the heart blood type treated by Fufang Sanqi Humai Tang(复方三七护脉汤) combined with routine Western medicine treatment
作者:
王磊1 姚淮芳2
1. 安徽中医药大学研究生部, 安徽 合肥 230038;
2. 安徽中医药大学第一附属医院老年心血管病科, 安徽 合肥 230031
Author(s):
WANG Lei1 YAO Huaifang2
1. Faculty of Postgraduate, Anhui University of Chinese Medicine, Hefei, Anhui, 230038, China;
2. Department of Geriatric Cardiovascular Disease, the First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, 230031, China
关键词:
冠心病稳定型心绞痛心血瘀阻型复方三七护脉汤临床观察
Keywords:
stable angina pectoris of coronary heart diseasestagnation of the heart blood typeFufang Sanqi Humai Tang(复方三七护脉汤)clinical observation
分类号:
R259.414
DOI:
10.16841/j.issn1003-8450.2019.03.10
摘要:
目的 观察复方三七护脉汤联合西医常规治疗心血瘀阻型冠心病稳定型心绞痛的临床疗效。方法 将40例心血瘀阻型冠心病稳定型心绞痛患者采用随机数字表法分为对照组和治疗组,各20例。对照组采用西医常规治疗,治疗组在对照组治疗方法的基础上联合复方三七护脉汤治疗。6周为1个疗程,1个疗程后比较2组的临床疗效及治疗前后血清总胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)水平。结果 对照组总有效率为75%,治疗组为90%,2组比较差异有统计学意义(P<0.05);2组治疗后血清TC、TG、LDL-C水平均明显下降,血清HDL-C水平明显升高,与同组治疗前比较差异有统计学意义(P<0.05),且治疗组对各项指标的改善作用更明显,2组治疗后比较差异均有统计学意义(P<0.05)。结论 复方三七护脉汤联合西医常规治疗心血瘀阻型冠心病稳定型心绞痛临床疗效显著,可明显改善患者的血脂水平,值得临床推广应用。
Abstract:
Objective To observe the clinical efficacy of stable angina pectoris of coronary heart disease with stagnation of the heart blood type treated by Fufang Sanqi Humai Tang(复方三七护脉汤) combined with routine Western medicine treatment.Methods Forty cases of stable angina pectoris of coronary heart disease with stagnation of the heart blood type were divided into control group and treatment group according to random number table method,with 20 cases in each.The control group was given routine Western medicine treatment,while the treatment group was given Fufang Sanqi Humai Tang on the basis of the control group.Six weeks constituted a course of treatment, after 1 course of treatment the clinical efficacy,the serum total cholesterol(TC) level,the triglyceride(TG) level,the high density lipoprotein cholesterol(HDL-C) level,and the low density lipoprotein cholesterol(LDL-C) level before and after treatment of the two groups were compared.Results The total effective rate of the control group was 75%,that of the control group was 90%,there was statistically significant difference between the two groups(P<0.05).After treatment,the serum levels of TC,TG and LDL-C decreased signifcantly,while the serum level of HDL-C increased significantly in the two groups,there was statistically significant difference compared with the same group before treatment(P<0.05),moreover, the improvement effect of the treatment group on all the indicators was more significant,and the difference between the two groups after treatment was statistically significant(P<0.05).Conclusion It has marked clinical efficacy to use Fufang Sanqi Humai Tang combined with routine Western medicine in the treatment of stable angina pectoris of coronary heart disease with stagnation of the heart blood type.It can significantly improve the blood lipid level and is worthy of clinical promotion and application.

参考文献/References:

[1] 陈伟伟,高润霖,刘力生,等.《中国心血管病报告2017》概要[J].中国循环杂志,2018,33(1):1-8.
[2] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206.
[3] 陈灏珠,钟南山.内科学[M].8版.北京:人民卫生出版社,2013:232-233.
[4] 王阶,陈光.冠心病稳定型心绞痛中医诊疗专家共识[J].中医杂志,2018,59(5):447-450.
[5] 郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:77-85.
[6] 梁峰,胡大一,沈珠军,等.小剂量阿司匹林在心脑血管事件一级预防中的研究进展[J].中国医院用药评价与分析,2014,14(11):1044-1048.
[7] 赵晓敏.养心氏片联合单硝酸异山梨酯缓释片治疗冠心病心绞痛的疗效观察[J].中西医结合心脑血管病杂志,2017,15(2):211-213.
[8] 陈菲,周贝丽,郑燕萍.曲美他嗪对冠心病(CHD)稳定性劳力型心绞痛患者心肌缺血的影响[J].齐齐哈尔医学院学报,2017,38(8):930-932.
[9] 杜瑞雪,叶平,蔡剑鸣,等.长期调脂治疗对颈动脉粥样硬化斑块成分的影响[J].中华老年心脑血管病杂志,2018,20(7):696-699.
[10] 张松,姚淮芳,张叶祥,等.从"肾虚血瘀"治疗动脉粥样硬化研究简况[J].中医药临床杂志,2018,30(3):572-574.
[11] 李娟,王如锋,杨莉,等.三七皂苷类成分及对心血管作用的研究进展[J].中国中药杂志,2015,40(17):3480-3487.
[12] 梅雪,余刘勤,陈小云,等.何首乌化学成分和药理作用的研究进展[J].药物评价研究,2016,39(1):122-131.
[13] 楼陆军,罗洁霞,高云.山楂的化学成分和药理作用研究概述[J].中国药业,2014,23(3):92-94.
[14] 杨志霞,林谦,马利.丹参对心血管疾病药理作用的文献研究[J].世界中西医结合杂志,2012,7(2):93-96.
[15] 刘蕾,刘富岗,杨云,等.忍冬藤多糖抗氧化活性研究[J].中华中医药杂志,2014,29(6):1826-1829.

备注/Memo

备注/Memo:
收稿日期:2018-08-01。
作者简介:王磊(1991-),男,在读硕士研究生。研究方向:中医内科学心血管方向。
通信作者:姚淮芳(1965-),女,主任医师,教授,硕士生导师,医学硕士,主要从事中医心血管疾病的研究。E-mail:huaifangyao@163.com
更新日期/Last Update: 1900-01-01